Provenge

Treatment for Prostate Cancer

Update: Provenge Now FDA Approved - April 29, 2010

Prostate Cancer Patients, Survivors and Advocates Assemble on Capitol Hill to Rally against FDA's Non Approval of Provenge

(BUSINESS WIRE)--June 1, 2007 - ProvengeNow:

Who: Prostate cancer patients, survivors, physicians and advocates have formed a coalition called ProvengeNow to fight the recent decision by the Food and Drug Administration (FDA) to delay the approval of Provenge. Jan Manarite of the Prostate Cancer Research Institute (PCRI) and Raise A Voice is coordinating the rally and speakers will include: Thomas A. Farrington, a Prostate Cancer survivor and President & CEO of the Prostate Health Education Network (PHEN); Jim Kiefert Chairman of the Board, Us TOO!; and Dr. Mark A. Moyad M.D., M.P.H., University of Michigan Medical Center.

What: ProvengeNow coalition members, patients, physicians and advocates will assemble on Capitol Hill to petition Congress and rally against the recent FDA decision to delay approval of Provenge, a first of its kind cancer vaccine that would extend survival and increase the quality of life for late stage cancer patients. Hundreds of supporters are expected to attend including members of prostate cancer advocate groups, Us TOO!, Prostate Health Education Network (PHEN),Prostate Cancer Research Institute(PCRI), Survivors Celebration, Raise A Voice and Patient Advocates for Advanced Cancer Treatments (PAACT).

When: Monday June 4, 2007 at 10:00 A.M.

Where: Upper Senate Park (adjacent to the Russell Senate Office Building), Capitol Hill, Washington D.C.

(1) Photo opportunities available as rally participants march from Union Station to Upper Senate Park, beginning at 9:30 AM

About ProvengeNow:

ProvengeNow Coalition Members include Us TOO, Prostate Health Education Network (PHEN), Prostate Cancer Research Institute (PCRI), Survivors Celebration, Raise A Voice and Patient Advocates for Advanced Cancer Treatments (PAACT). Dr. Mark A. Moyad, M.D., M.P.H. is the Director and leader of the group of medical supporters including physicians and researchers.

Contact

Media Contact:
Spotlight Communications
Dhakir Warren, 617-423-0040
or
Event Contact:
Prostate Cancer Research Institute
Jan Manarite, 239-395-0995

Posted: June 2007

Related Articles

Provenge (sipuleucel-T) FDA Approval History

View comments

Hide
(web2)